期刊文献+

原发性骨肉瘤中EGFR和C-erbB-2的表达及其意义

The Expression and Significance of EGFR and C-erbB-2 in Primary Osteosarcoma
下载PDF
导出
摘要 检测20例原发性骨肉瘤和10例骨纤维结构不良中EGFR和C-erbB-2的表达;两者在骨肉瘤中表达的阳性率分别为50%和40%(P<0.05),而在骨纤维结构不良中分别为10%和0%(P<0.05);骨肉瘤中EGFR和C-erbB-2表达均高于骨纤维结构不良,且呈正相关,这为骨肉瘤的诊疗提供了理论依据。 The expression of EGFR and C-erbB-2 were tested in 20 primary osteosarcoma (OS) patients and 10 osteofibrous dysplasia (OFD) patients in this study.??We find the positive expression rates of EGFR and C-erbB-2 are 50%and 40%(P〈0.05) in OS, respectively and those in OFD are 10% and 0%(P〈0.05), respectively. So the expression levels of EGFR and C-erbB-2 in OS are significantly higher than those in ODF. Furthermore,the expression level of EGFR and C-erbB-2 is positively correlated between them, which are valuable in diagnosis and therapy for primary osteosarcoma.
出处 《医学与哲学(B)》 2009年第11期59-60,70,共3页 Medicine & Philosophy(B)
关键词 骨肉瘤 EGFR蛋白 C-erbB-2蛋白 osteosarcoma,EGFR protein,C-erbB-2 protein
  • 相关文献

参考文献3

二级参考文献55

  • 1BAZLEy L A , GULLICK W J. The Epidermal Growth Factor Receptor Family [ J ]. Endocr Relat Cancer, 2005,12:S17-27.
  • 2HUBBARD S R, MILLER W T. Receptor Tyrosine Kinases: Mechanisms of Activation and Signaling [ J ]. Current Opinion in Cell Biology ,2007,19 : 117 - 123.
  • 3DAWSON J P, BERGER M B, LIN C C, et al. Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand - induced Conformational Changes in the Dimer Interface [ J ]. Molecular and Cellular Biology , 2005,25:7734 -7742.
  • 4AIFA S, AYDIN J, NORDVALL G, et al. A Basic Peptide Within the Juxtamembrane Region is Required for EGF Receptor Dimerization [ J ]. Experimental Cell Research ,2005,302 : 108 - 114.
  • 5SEBASTIAN S, SETrLEMAN J, RESHKIN S J, et al. The Complexity of Targeting EGFR Signalling in Cancer: from Expression to Turnover [ J ]. Biochim Biophys Acta,2006,1766( 1 ) : 120 -39.
  • 6OLSEN B B, NEVES-PETERSEN M T, KLITGAARD S, et al. UV Light Hocks EGFR Signalling in Human Cancer Cell Lines [ J ]. International Journal of Oncology,2007,30 : 181 - 185.
  • 7GOLDONI S, IOZZO R A, KAY P, et al. A Soluble Ectodomain of LRIG1 Inhibits Cancer Cell Growth by Attenuating Basal and Ligand - dependent EGFR Activity[ J]. Oncogene,2007 ,26 :368 - 381.
  • 8SCHLEY P D, BRINDLEY D N, FIELD C J. (n -3) PUFA Alter Raft Lipid Composition and Decrease Epidermal Growth Factor Receptor Levels in Lipid Rafts of Human Breast Cancer Cells [ J ]. The Journal of Nutrition ,2007,137:548 - 553.
  • 9PARK S S, KIM JE, KIM Y A, et al. Caveolin -1 is Down- regulated and Inversely Correlated with HER2 and EGFR Expression Status in Invasive Ductal Carcinoma of the Breast [ J ]. Histopathology ,2005,47:625 - 630.
  • 10Milano A, Longo F,Basile M, et al. Recent advances in the treatmenl of salivary gland cancers:Emphasis on molecular targeted therapy [J]. Oral Oncology, 2007,43 (8) : 729-734.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部